KR102163775B9 - 7--44--1--7H-[23-d] 7-benzyl-4-4-phenylpiperazin-1-yl-7H-pyrrolo[23-d]pyrimidine derivatives and Composition for skin whitening and Pharmaceutical composition for use in preventing or treating disorders of Melanin Hyperpigmentation containing the same as an active ingredient - Google Patents

7--44--1--7H-[23-d] 7-benzyl-4-4-phenylpiperazin-1-yl-7H-pyrrolo[23-d]pyrimidine derivatives and Composition for skin whitening and Pharmaceutical composition for use in preventing or treating disorders of Melanin Hyperpigmentation containing the same as an active ingredient

Info

Publication number
KR102163775B9
KR102163775B9 KR1020190022646A KR20190022646A KR102163775B9 KR 102163775 B9 KR102163775 B9 KR 102163775B9 KR 1020190022646 A KR1020190022646 A KR 1020190022646A KR 20190022646 A KR20190022646 A KR 20190022646A KR 102163775 B9 KR102163775 B9 KR 102163775B9
Authority
KR
South Korea
Prior art keywords
composition
phenylpiperazin
pyrrolo
benzyl
preventing
Prior art date
Application number
KR1020190022646A
Other languages
Korean (ko)
Other versions
KR102163775B1 (en
KR20200104476A (en
Inventor
최상운
정관령
손지유
박철민
유미연
Original Assignee
한국화학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국화학연구원 filed Critical 한국화학연구원
Priority to KR1020190022646A priority Critical patent/KR102163775B1/en
Publication of KR20200104476A publication Critical patent/KR20200104476A/en
Application granted granted Critical
Publication of KR102163775B1 publication Critical patent/KR102163775B1/en
Publication of KR102163775B9 publication Critical patent/KR102163775B9/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03Organic compounds
    • A23L29/045Organic compounds containing nitrogen as heteroatom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
KR1020190022646A 2019-02-26 2019-02-26 7-benzyl-4-(4-phenylpiperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine derivatives and Composition for skin whitening and Pharmaceutical composition for use in preventing or treating disorders of Melanin Hyperpigmentation containing the same as an active ingredient KR102163775B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190022646A KR102163775B1 (en) 2019-02-26 2019-02-26 7-benzyl-4-(4-phenylpiperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine derivatives and Composition for skin whitening and Pharmaceutical composition for use in preventing or treating disorders of Melanin Hyperpigmentation containing the same as an active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190022646A KR102163775B1 (en) 2019-02-26 2019-02-26 7-benzyl-4-(4-phenylpiperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine derivatives and Composition for skin whitening and Pharmaceutical composition for use in preventing or treating disorders of Melanin Hyperpigmentation containing the same as an active ingredient

Publications (3)

Publication Number Publication Date
KR20200104476A KR20200104476A (en) 2020-09-04
KR102163775B1 KR102163775B1 (en) 2020-10-12
KR102163775B9 true KR102163775B9 (en) 2022-07-18

Family

ID=72471003

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190022646A KR102163775B1 (en) 2019-02-26 2019-02-26 7-benzyl-4-(4-phenylpiperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine derivatives and Composition for skin whitening and Pharmaceutical composition for use in preventing or treating disorders of Melanin Hyperpigmentation containing the same as an active ingredient

Country Status (1)

Country Link
KR (1) KR102163775B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150062272A (en) * 2013-11-29 2015-06-08 (주)아모레퍼시픽 Cosmetic composition for skin-whitening stably containing kojic acid

Also Published As

Publication number Publication date
KR102163775B1 (en) 2020-10-12
KR20200104476A (en) 2020-09-04

Similar Documents

Publication Publication Date Title
NZ603686A (en) Topical formulation for a jak inhibitor
CR20220316A (en) Substituted tetrahydrofurans as modulators of sodium channels
IL216741A (en) 1,3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating diseases
BR112016008016B8 (en) kras g12c inhibitory compounds, pharmaceutical composition comprising said compounds, methods for regulating the activity and for preparing a kras, hras or nras g12c mutant protein, method for inhibiting the proliferation of a population of cells and therapeutic uses of said compounds
PL2210588T3 (en) Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
NZ590796A (en) Film-forming liquid formulations for drug release to hair and scalp
IL127943A0 (en) Pharmaceutical and cosmetic composition for the treatment of skin disorders
ES2267706T3 (en) AGENTS AS NICOTINAMIDE OR CARDR FOR THE TREATMENT OF SKIN DISORDERS.
IL284930A (en) Pyrrolopyrimidine derivative, and pharmaceutical composition for preventing or treating protein kinase-related disease comprising same as active ingredient
IL291168A (en) Heteroarylamidopyridinol derivative and pharmaceutical composition comprising same as active ingredient for prevention or treatment of autoimmune disease
EP3915985A4 (en) Pyrrolopyridine derivative and use thereof in prevention and treatment of protein kinase-related disease
MX2016016400A (en) Stabilized oxymetazoline formulations and their uses.
EP3852760A4 (en) Matter of composition, synthesis, formulation and application of fl118 platform positions 7 and 9-derived analogues for treatment of human disease
EP3848032A4 (en) Application of pyrroloquinoline quinone in preparation of medicament used for preventing and treating acute altitude sickness and acute altitude hypoxia injury
MX341660B (en) Ghrelin receptor agonist for treatment of dyscrasia.
KR102163775B9 (en) 7--44--1--7H-[23-d] 7-benzyl-4-4-phenylpiperazin-1-yl-7H-pyrrolo[23-d]pyrimidine derivatives and Composition for skin whitening and Pharmaceutical composition for use in preventing or treating disorders of Melanin Hyperpigmentation containing the same as an active ingredient
NZ718802A (en) Icotinib-containing topical skin pharmaceutical composition and use thereof
EP3909576A4 (en) Use of chlorogenic acid in preparing medicine or pharmaceutical composition for preventing or treating pain
EP3549596A4 (en) Use of microcystins in preparation of drugs for preventing or treating organ and tissue fibrosis diseases
PT3937948T (en) Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases
IL192971A0 (en) Use of mimosine or a derivative thereof for treating the cutaneous effects of psoriasis and related skin disorders, and cosmetic or pharmaceutical composition containing same
Grimes Vitiligo: Management and prognosis
EP4005572A4 (en) Benzamide derivative, preparation method therefor, and pharmaceutical composition comprising same as active ingredient for prevention or treatment of cancer
EP4052719A4 (en) Traditional chinese medicine composition for treating egfr-tkis related skin rash and use thereof
SG11202112914SA (en) Pyrido-pyrimidin derivatives and pharmaceutical composition, for use in preventing or treating pi3 kinase related diseases, comprising same as active ingredient

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
G170 Re-publication after modification of scope of protection [patent]